Human domain antibodies to conserved epitopes on her2 potently inhibit growth of her2-overexpressing human breast cancer cells in vitro

HIGHLIGHTS

• who: Hongqian Wang and colleagues from the The Second Clinical Medicine School, Zhejiang Chinese Medical University, Hangzhou, China have published the Article: Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro, in the Journal: Antibodies 2019, 8, x FOR PEER REVIEW of /2019/
• what: The authors report the identification and characterization of fully human single-domain antibodies (dAbs) targeting epitopes that are highly conserved among various species and non-overlapping with those of trastuzumab and pertuzumab. In this a fully human VH-based dAb . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.